Real-world evidence from the most extensive comparative effectiveness study demonstrated that GLP-1 RA-nave patients initiating tirzepatide achieved significantly greater HbA1c reduction compared to those initiating semaglutide (1.3% vs
By targeting specific cellular pathways, it may support fat reduction, improve energy balance, and promote overall metabolic health
doi: 10.1016/S2213-8587(22)00085-7 41 AdriaenssensAEBiggsEKDarwishTTadrossJSukthankarTGirishMet al
Key Findings from Energy Research: Athletic Performance and Recovery Benefits Athletes see better performance and quicker recovery with X39
Meanwhile, on Tuesday, Novo announced that its triple-G agonist, UBT251, led to 19.7% weight loss after 24 weeks in a Phase 2 trial based in China
As much as 40% of all weight lost on GLP-1s is lean muscle, says Mahmoud Salama Ahmed, a medical chemist at Texas Tech University